One-Time_Notification_Manual / 3818

Why This Topic Matters

The article addresses changes and corrections that affect how drug administration services are categorized and reported under Medicare policy. It is important for organizations that need to stay aligned with CMS instructions and CPT-adopted guidance during the transition period described in the transmittal.

Article Sections

1. General Information

   Background on the transmittal, the policy context, and the source of the revised drug administration guidance. It also introduces the overall administrative framework and timing.

2. Policy

   Discussion of the drug administration guideline revisions, including general topics such as short-duration administration, concurrent infusions, and the meaning of initial service. The section also notes CMS adoption and related implementation details.

3. Implementation of Revised Coding Guidelines

   Information on when the revised guidance becomes effective and how carriers are instructed to handle claims under the updated policy.

4. Corrections

   Clarifications and corrections to previously issued transmittal language, including adjustments tied to hydration therapy and same-day service reporting. This section focuses on updates to earlier instructions.

5. Business Requirements

   Administrative implementation material referenced in the transmittal. The underlying chart is unavailable in the source text.

6. Provider Education

   Provider-facing education material referenced in the transmittal. The underlying chart is unavailable in the source text.

7. Supporting Information and Possible Design Considerations

   Supplementary implementation notes and system-design categories associated with the transmittal. Several subsections are listed as not applicable.

8. Schedule, Contacts, and Funding

   Effective and implementation dates, contact information, and funding notes associated with the transmittal.